سعر اريثروميسين فاركو 200مجم/5مل شراب معلق 60 مل 2022

Erythromycin Pharco: erythromycin 200 mg/5 mL oral suspension, 60 mL bottle; macrolide antibiotic.

• Mild to moderate upper and lower respiratory tract infections caused by susceptible Streptococcus pyogenes or Streptococcus pneumoniae (H. influenzae only with concomitant sulfonamide).Population: Adults and childrenDailyMed (U.S. National Library of Medicine)
• Skin and skin structure infections of mild to moderate severity caused by susceptible Streptococcus pyogenes or Staphylococcus aureus; also diphtheria (adjunct to antitoxin), erythrasma, pertussis, Legionnaires disease, chlamydial and other listed infections.Population: Adults and childrenDailyMed (U.S. National Library of Medicine)
• Prevention of initial and recurrent attacks of rheumatic fever in penicillin-allergic patients.Population: Penicillin-allergic patientsDailyMed (U.S. National Library of Medicine)

• Most frequent: dose-related gastrointestinal effects (nausea, vomiting, abdominal pain, diarrhoea, anorexia). Also reported: hepatic dysfunction, allergic reactions from urticaria to anaphylaxis, rare severe skin reactions (erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis), and reversible hearing loss mainly with renal insufficiency or high doses.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to erythromycin.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Contraindicated in patients taking terfenadine, astemizole, pimozide or cisapride; do not use with CYP3A4-metabolised statins (lovastatin or simvastatin) because of the risk of myopathy including rhabdomyolysis.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hepatic dysfunction, including increased liver enzymes and hepatocellular and/or cholestatic hepatitis with or without jaundice, has been reported with oral erythromycin.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• QT prolongation and ventricular arrhythmias including torsades de pointes have been reported; avoid in patients with known QT prolongation, uncorrected hypokalaemia or hypomagnesaemia, clinically significant bradycardia, or on class IA/III antiarrhythmics; elderly patients may be more susceptible.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Clostridioides difficile-associated diarrhoea has been reported with nearly all antibacterial agents and may range from mild diarrhoea to fatal colitis.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• TheophyllineHigh-dose theophylline levels may rise with possible toxicity; reduce theophylline dose if needed.DailyMed (U.S. National Library of Medicine)
• DigoxinElevated digoxin serum levels have been reported.DailyMed (U.S. National Library of Medicine)
• Oral anticoagulants (e.g. warfarin)Increased anticoagulant effect, possibly more pronounced in the elderly.DailyMed (U.S. National Library of Medicine)

• Animal studies (rats, mice, rabbits) showed no evidence of teratogenicity with erythromycin base; the label notes reports that erythromycin may not reach the fetus in adequate concentration to prevent congenital syphilis, so infants of mothers treated for early syphilis should receive penicillin.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Erythromycin is excreted in human milk; use with caution in nursing women.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Erythromycin: Macrolide antibacterial: binds the 50S ribosomal subunit of susceptible organisms and inhibits protein synthesis; it does not affect nucleic acid synthesis.